Replies to post #72051 on Biotech Values

[genisi]

Re: Cladribine for MS

Teva as always doesn't say much and I think that royalties were not disclosed by Merk/Serono or Ivax either. But analysts were talking a mid-teens (15% max) royalty on sales to Ivax.